Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients

Table 1

Demographic and clinical characteristics of healthy controls and OND and RRMS patients.

	Healthy controls ()	OND ()	MS ()
Age	37.0 ± 7.5; 35.5 (30.3–44.0)	42.4 ± 13.7; 41.5 (33.0–49.0)	39.2 ± 10.9; 37.0 (30.5–48.0)
Sex: female/male	24/16	57/35	53/36
Disease duration (yrs)	—	—	5.9 ± 7.1; 3 (1–7.7)
EDSS	—	—	3.8 ± 1.9; 3.5 (2.5–4.4)
Clinically active MS: /total (%)	—	—	32/40 (80%)
Clinically stable MS: /total (%)	—	—	8/40 (20%)

EDSS: expanded disability status scale; MS: multiple sclerosis; RRMS: relapsing-remitting multiple sclerosis; OND: other neurological disorders.